Piper Jaffray Companies started coverage on shares of Randsburg International Gold (OTCMKTS:CRLBF) in a research note issued to investors on Monday morning, BenzingaRatingsTable reports. The firm issued an overweight rating and a $11.00 target price on the stock.
Separately, Compass Point initiated coverage on shares of Randsburg International Gold in a research report on Monday, June 10th. They set a buy rating on the stock.
Shares of OTCMKTS:CRLBF opened at $8.48 on Monday. The stock’s 50 day simple moving average is $8.82. Randsburg International Gold has a 12-month low of $4.19 and a 12-month high of $14.39.
Cresco Labs Inc manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products. The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews.
Further Reading: Net Income
Receive News & Ratings for Randsburg International Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Randsburg International Gold and related companies with MarketBeat.com's FREE daily email newsletter.